Board Member
Rockwell Medical, Inc. (RMTI)Equibles does not estimate personal net worth.
Get an email with a short summary when Rockwell Medical, Inc. publishes a filing, an earnings call transcript or a press release.
Get RMTI alertsRussell Ellison is recorded as CEO and Board Member at Rockwell Medical, Inc. (RMTI). The proxy statement of Rockwell Medical, Inc. reports total compensation of $712,128 for Russell Ellison in fiscal 2022, including a base salary of $275,327. Disclosed compensation is on record for 3 fiscal years. Russell Ellison has spoken on 8 earnings calls across 1 company, most recently for Rockwell Medical, Inc. on May 16, 2022. Rockwell Medical, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Rockwell Medical, Inc. includes Mark Strobeck (CEO and Board Member), Mark Strobeck, Ph.D. (CEO and Board Member), Russell H. Ellison, M.D., M.Sc. (CEO) and 7 others.
“Rockwell Medical is a biotech company, but with revenue, and that makes us fairly unique. We have a proprietary drug technology called ferric pyrophosphate citrate, or FPC, which is a next-generation therapy for iron deficiency.”
“In the third quarter of 2021, we continued to progress our strategy with improvements on the solid foundation and reputation of our dialysis business, combined with advancement in the development of our FPC platform outside of dialysis.”
“In the second quarter of 2021, we continued to execute against our strategy to accelerate growth by combining the solid foundation, strength, and reputation of our dialysis business with the development of our FPC platform in multiple disease states.”
“Since it has only been about six weeks since our last earnings call, where we detailed for you our strategy, we will keep this call short.”
“Like most companies around the world, we faced challenges during the COVID-19 pandemic. And I'm proud of how our team stepped up. Our people created and followed strict protocols.”
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Rockwell Medical, Inc. (RMTI) | Former Chief Executive Officer^(b)^ | $275,327 | $712,128 |
| 2021 | Rockwell Medical, Inc. (RMTI) | Former Chief Executive Officer^(b)^ | $501,135 | $627,537 |
| 2020 | Rockwell Medical, Inc. (RMTI) | Chief Executive Officer(a) | $367,687 | $2,480,632 |
